Low-dose cortisone for male infertility

Area of Science:

• Endocrinology
• Reproductive Medicine
• Infertility Research

Background:

• Idiopathic infertility affects a significant number of males.
• Hormonal therapies, including thyroid and cortisone, have been explored for male infertility.
• Limited evidence exists on the efficacy of low-dose hormonal treatments.

Purpose of the Study:

• To evaluate the efficacy of low-dose thyroid and low-dose cortisone in treating idiopathic male infertility.
• To compare pregnancy rates and semen parameters between the two treatment groups.

Main Methods:

• A randomized study involving 38 males with idiopathic infertility.
• Participants were treated with either low-dose thyroid or low-dose cortisone.
• Semen analysis (sperm count and motility) and pregnancy outcomes were assessed.

Main Results:

• No statistically significant difference in pregnancy rates was observed between cortisone (7/33) and thyroid (4/30) treatments (P = 0.5).
• Mean post-treatment sperm counts showed no significant difference: thyroid (11.2 million/ml) vs. cortisone (13 million/ml) (P = 0.4).
• Sperm motility also remained unchanged: thyroid (44%) vs. cortisone (43%) (P = 0.7).

Conclusions:

• Low-dose cortisone and thyroid treatments do not appear to significantly improve outcomes for idiopathic male infertility.
• Pregnancy rates in this cohort correlated with pretreatment sperm counts, not the specific hormonal treatment.
• The efficacy of low-dose cortisone for idiopathic infertility warrants further investigation and appears questionable based on these findings.